- Home
- AMC vs RXST Comparison
AMC vs RXST Comparison
Compare AMC & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMC
- RXST
- Stock Information
- Founded
- AMC 1920
- RXST 1997
- Country
- AMC United States
- RXST United States
- Employees
- AMC N/A
- RXST N/A
- Industry
- AMC Movies/Entertainment
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AMC Consumer Discretionary
- RXST Health Care
- Exchange
- AMC Nasdaq
- RXST Nasdaq
- Market Cap
- AMC 1.2B
- RXST 1.0B
- IPO Year
- AMC 2013
- RXST 2021
- Fundamental
- Price
- AMC $3.55
- RXST $15.29
- Analyst Decision
- AMC Hold
- RXST Buy
- Analyst Count
- AMC 7
- RXST 10
- Target Price
- AMC $3.92
- RXST $39.30
- AVG Volume (30 Days)
- AMC 14.8M
- RXST 1.1M
- Earning Date
- AMC 05-07-2025
- RXST 05-07-2025
- Dividend Yield
- AMC N/A
- RXST N/A
- EPS Growth
- AMC N/A
- RXST N/A
- EPS
- AMC N/A
- RXST N/A
- Revenue
- AMC $4,548,300,000.00
- RXST $148,310,000.00
- Revenue This Year
- AMC $7.95
- RXST $22.25
- Revenue Next Year
- AMC $6.09
- RXST $18.58
- P/E Ratio
- AMC N/A
- RXST N/A
- Revenue Growth
- AMC N/A
- RXST 46.70
- 52 Week Low
- AMC $2.45
- RXST $12.53
- 52 Week High
- AMC $5.96
- RXST $61.10
- Technical
- Relative Strength Index (RSI)
- AMC 63.77
- RXST 47.18
- Support Level
- AMC $2.88
- RXST $15.66
- Resistance Level
- AMC $4.08
- RXST $16.48
- Average True Range (ATR)
- AMC 0.26
- RXST 0.89
- MACD
- AMC 0.08
- RXST 0.36
- Stochastic Oscillator
- AMC 62.41
- RXST 65.56
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.